Unituxin 3.5 mg / ml Concentrate for the preparation of an infusion solution
1 ml concentrate contains 3.5 mg dinutuximab.
For the treatment of high-risk neuroblastoma in patients aged 12 months to 17 years who received induction chemotherapy and achieved at least one partial remission, followed by myeloablative therapy and autologous stem cell transplantation (ASCT).
It is used in combination with granulocyte macrophage colony stimulating factor (GM-CSF), interleukin-2 (IL-2) and isotretinoin.
Storage temperature: 2-8 ° C